We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial.
- Authors
Suhler, Eric B; Lowder, Careen Y; Goldstein, Debra A; Giles, Tracy; Lauer, Andreas K; Kurz, Paul A; Pasadhika, Sirichai; Lee, Shelly T; de Saint Sardos, Alexandre; Butler, Nicholas J; Tessler, Howard H; Smith, Justine R; Rosenbaum, James T
- Abstract
Tumour necrosis factor (TNF) blockers have been demonstrated to be effective in the treatment of systemic and ocular inflammatory diseases. We conducted a prospective, multicentre, open-label Phase II clinical trial to assess the effectiveness and safety of adalimumab, a fully human anti-TNF monoclonal antibody, in treating refractory uveitis.
- Publication
The British journal of ophthalmology, 2013, Vol 97, Issue 4, p481
- ISSN
1468-2079
- Publication type
Journal Article
- DOI
10.1136/bjophthalmol-2012-302292